About Peerbridge Health
Peerbridge Health is a private company based in New York, New York. It has reported $60,387,295 raised in 13 offerings on Form D since January 2015. Its chief executive is Chris Darland.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 9, 2025 | Aug 15, 2025 | $7,181,000of $8.0M target | 25 | $287K | EquityRule 506(b) | Form D ↗ |
| Jun 5, 2024 | Jun 20, 2024 | $13,711,488of $19.3M target | 28 | $489K | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Feb 15, 2023 | Feb 28, 2023 | $5,047,089of $10.0M target | 26 | $194K | Equity, CONVERTIBLE NOTESRule 506(b) | Form D ↗ |
| Oct 11, 2022 | Oct 14, 2022 | $725,000of $4.0M target | 4 | $181K | Options, convertible notesRule 506(b) | Form D ↗ |
| Jan 31, 2022 | Feb 14, 2022 | $7,494,460of $10.6M target | 24 | $312K | Options, CONVERTIBLE NOTESRule 506(b) | Form D ↗ |
| Apr 22, 2021 | May 5, 2021 | $3,134,977of $5.0M target | 4 | $783K | Options, convertible notesRule 506(b) | Form D ↗ |
| Aug 21, 2020 | Aug 25, 2020 | $2,655,000fully sold | 1 | $2.6M | EquityRule 506(b) | Form D ↗ |
| Mar 24, 2020 | Apr 2, 2020 | $393,667of $3.7M target | 11 | $35,788 | Options, CONVERTIBLE NOTESRule 506(b) | Form D ↗ |
| Oct 31, 2019 | Nov 5, 2019 | $10,949,433of $20.0M target | 10 | $1.0M | Options, CONVERTIBLE NOTESRule 506(b) | Form D ↗ |
| May 23, 2018 | Jun 4, 2018 | $1,475,000of $5.0M target | 11 | $134K | Options, convertible notesRule 506(b) | Form D ↗ |
| Mar 10, 2017 | Mar 23, 2017 | $1,725,000of $3.0M target | 11 | $156K | Options, Convertible NoteRule 506(b) | Form D ↗ |
| Mar 21, 2016 | Mar 31, 2016 | $1,000,000of $55.0M target | 1 | $1.0M | Equity, OptionsRule 506(b) | Form D ↗ |
| Dec 23, 2014 | Jan 6, 2015amended Jan 7, 2015 | $4,895,181of $8.9M target | 7 | $699K | Equity, OptionsRule 506(b) | Form D/A ↗2 earlier filings |
| Total, 13 offerings | $60,387,295 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Peerbridge Health's Form D filed Aug 15, 2025.
Earlier filings also listed Tamanna Bembenek, Ph.D. (director, last listed Jun 2024), Greg Tracy (director, last listed Feb 2023), Todd Asmuth (ceo and director, last listed Oct 2022), Richard Mulry (director, last listed Oct 2022), Angelo Acquista (director, last listed Oct 2022), Michael Fawkes (executive officer and director, last listed Feb 2022), Adrian Gilmore (chief executive officer and director, last listed Feb 2022) and Avi Kometz (director, last listed Aug 2020).